Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy
Source abstract
Abstract
Responsive drug delivery systems possess great potential in disease diagnosis and treatment. Herein, we develop an activatable prodrug and fluorescence imaging material by engineering the endogenous NAD(P)H:quinone oxidoreductase-1 (NQO1) responsive linker. The as-prepared nanomaterials possess the NQO1-switched drug release and fluorescence enablement, which realizes the tumor-specific chemotherapy and imaging in living mice. The enzyme-sensitive prodrug nanoparticles exhibit selectively potent anticancer performance to NQO1-positive cancer and ignorable off-target toxicity. This work provides an alternative strategy for constructing smart prodrug nanoplatforms with precision, selectivity, and practicability for advanced cancer imaging and therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China
University of Science and Technology of China, Hefei, Anhui 230026, P. R. China
Funding
Natural Science Foundation of Jilin Province · National Natural Science Foundation of China
References (65)
Show source-provided references
1. 10.1038/nrc152910.1038/nrc1529 ↗
2. 10.1038/s41565-019-0567-y10.1038/s41565-019-0567-y ↗
3. 10.1093/nsr/nwz01210.1093/nsr/nwz012 ↗
4. 10.1021/jacs.1c0031210.1021/jacs.1c00312 ↗
5. 10.1038/nrd.2018.4610.1038/nrd.2018.46 ↗
6. 10.1039/C7CS00521K10.1039/C7CS00521K ↗
7. 10.1038/s41563-020-0674-z10.1038/s41563-020-0674-z ↗
8. 10.1021/acsami.1c1235310.1021/acsami.1c12353 ↗
9. 10.1021/acsnano.7b0821910.1021/acsnano.7b08219 ↗
10. 10.1038/s41467-019-11193-x10.1038/s41467-019-11193-x ↗
11. 10.1016/j.jconrel.2017.03.39110.1016/j.jconrel.2017.03.391 ↗
12. 10.1021/acs.chemmater.0c0408010.1021/acs.chemmater.0c04080 ↗
13. 10.1021/acsami.0c2171010.1021/acsami.0c21710 ↗
14. 10.1021/acs.nanolett.9b0534010.1021/acs.nanolett.9b05340 ↗
15. 10.1021/acs.nanolett.0c0197310.1021/acs.nanolett.0c01973 ↗
16. 10.1021/acsami.9b0903110.1021/acsami.9b09031 ↗
17. 10.1016/j.addr.2017.06.01310.1016/j.addr.2017.06.013 ↗
18. 10.1039/C6CS00908E10.1039/C6CS00908E ↗
19. 10.1038/s41557-021-00711-410.1038/s41557-021-00711-4 ↗
20. 10.1039/C8CS00395E10.1039/C8CS00395E ↗
21. 10.1002/adma.20190721010.1002/adma.201907210 ↗
22. 10.1126/sciimmunol.aau658410.1126/sciimmunol.aau6584 ↗
23. 10.1021/acsami.0c1197110.1021/acsami.0c11971 ↗
24. 10.1021/acsami.1c0389010.1021/acsami.1c03890 ↗
25. 10.1038/s41467-018-07490-610.1038/s41467-018-07490-6 ↗
26. 10.1021/jacs.1c0301310.1021/jacs.1c03013 ↗
27. 10.1002/adfm.20200740210.1002/adfm.202007402 ↗
28. 10.1016/j.biomaterials.2020.12032910.1016/j.biomaterials.2020.120329 ↗
29. 10.1016/j.biomaterials.2021.12106110.1016/j.biomaterials.2021.121061 ↗
30. 10.1016/j.jconrel.2020.10.06510.1016/j.jconrel.2020.10.065 ↗
31. 10.1021/acsami.6b1444610.1021/acsami.6b14446 ↗
32. 10.1002/adfm.20180512810.1002/adfm.201805128 ↗
33. 10.1002/adhm.20170038510.1002/adhm.201700385 ↗
34. 10.1002/anie.20191612410.1002/anie.201916124 ↗
35. 10.1002/smll.20200428010.1002/smll.202004280 ↗
36. 10.1002/smll.20190674410.1002/smll.201906744 ↗
37. 10.1038/s41467-019-11238-110.1038/s41467-019-11238-1 ↗
38. 10.1002/advs.20180180710.1002/advs.201801807 ↗
39. 10.1016/j.biomaterials.2018.12.03210.1016/j.biomaterials.2018.12.032 ↗
40. 10.1039/C5CC02149A10.1039/C5CC02149A ↗
41. 10.1021/acsnano.0c0076410.1021/acsnano.0c00764 ↗
42. 10.1016/S1470-2045(17)30401-110.1016/S1470-2045(17)30401-1 ↗
43. 10.1002/anie.20200873210.1002/anie.202008732 ↗
44. 10.1016/j.bmcl.2013.08.06610.1016/j.bmcl.2013.08.066 ↗
45. 10.1016/j.jconrel.2014.12.02710.1016/j.jconrel.2014.12.027 ↗
46. 10.1002/anie.20181303210.1002/anie.201813032 ↗
47. 10.1021/acs.accounts.5b0036510.1021/acs.accounts.5b00365 ↗
48. 10.1021/jacs.9b0866910.1021/jacs.9b08669 ↗
49. 10.1021/ja062012b10.1021/ja062012b ↗
50. 10.1021/jacs.7b0154810.1021/jacs.7b01548 ↗
51. 10.1021/ja309346f10.1021/ja309346f ↗
52. 10.1039/C6SC02236G10.1039/C6SC02236G ↗
53. 10.1016/j.ccell.2016.11.00610.1016/j.ccell.2016.11.006 ↗
54. 10.1021/bi300760u10.1021/bi300760u ↗
55. 10.1016/j.dyepig.2017.06.02910.1016/j.dyepig.2017.06.029 ↗
56. 10.1021/jacs.1c0211210.1021/jacs.1c02112 ↗
57. 10.1039/C9SC03355F10.1039/C9SC03355F ↗
58. 10.1038/s41467-021-22855-010.1038/s41467-021-22855-0 ↗
59. 10.1039/c3sc50252j10.1039/c3sc50252j ↗
60. 10.1002/adfm.20190660510.1002/adfm.201906605 ↗
61. 10.1021/jacs.9b1262910.1021/jacs.9b12629 ↗
62. 10.1038/srep1886810.1038/srep18868 ↗
63. 10.1016/j.dyepig.2017.04.04310.1016/j.dyepig.2017.04.043 ↗
64. 10.1021/acsnano.9b0828510.1021/acsnano.9b08285 ↗
65. 10.1002/anie.20080342810.1002/anie.200803428 ↗